Watch videos of patients with huntington's disease (hd) chorea and their care partners discussing hd chorea and their treatment experience with austedo xr® (deutetrabenazine) tablets. The majority of people with td or chorea associated with huntington disease (hd) who were treated with austedo xr (deutetrabenazine The most common adverse reactions for austedo (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia Austedo (deutetrabenazine) is a vesicular monoamine transporter 2 (vmat2) inhibitor for oral administration It is used in the treatment of tardive dyskinesia and chorea in patients with huntington’s disease. Online survey studying how hd chorea affects patients and caregivers, and the impact of deutetrabenazine (austedo xr/austedo) on quality of life.
Austedo user reviews & ratings austedo has an average rating of 6.9 out of 10 from a total of 14 reviews on drugs.com 57% of reviewers reported a positive experience, while 14% reported a negative experience. The survey included adults with td or huntington’s disease (hd) chorea who were prescribed the medication
WATCH
